Volume 28, Number 1—January 2022
CME ACTIVITY - Synopsis
Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007–2020
Table 1
Patient | Age, y/sex | Underlying condition | Exposure | Type of infection | Therapy | Outcome |
---|---|---|---|---|---|---|
1 | 67/F | Diabetes, endometrial cancer (remission) | Pigeon | Fungemia + UTI | FLC + CAS | Survived |
2 | 63/F | Esophagus squamous cell carcinoma | Pigeon | Mediastinitis after gastric ulceration | CAS | Survived |
3 | 66/M | CDP (endocrine carcinoma), recurrent angiocholitis | NA | Angiocholitis | FLC, surgery† | Survived |
4 | 84/F | Esophageal achalasia | None | Esophagitis | PPI, surgery‡ | Survived |
5 | 68/F | CVID, gastro–jejunal anastomotic stenosis | NA | Colonization | None | Survived |
6 | 46/M | Caustic esophageal stenosis, pneumonia |
NA | Colonization | None | Survived |
7 | 59/F | Systemic scleroderma | NA | Colonization | None | Died (cardiogenic shock) |
8 | 40/M | Former smoker, Staphylococcus ventilator-associated pneumonia | NA | Colonization | None | Survived |
9 | 51/F | AutoHSCT for oculo-cerebral NHL | NA | Colonization | FLC | Survived |
10 | 60/M | Proven Mycobacterium fortuitum infection | NA | Colonization | None | Survived |
11 | 59/M | COPD, emphysema, denutrition | NA | Colonization | None | Survived |
12 | 77/M | Congestive heart failure, ischemic cardiomyopathy, smoker | NA | Colonization | None | Died; multiorgan failure after cardiac surgery |
13 | 66/M | Angioimmunoblastic T-cell lymphoma, neutropenia, pulmonary tuberculosis | NA | Colonization | None | Died 5 mo later; cerebral toxoplasmosis, T-cell lymphoma progression |
*AutoHSCT, autologous hematopoietic stem cell transplantation; CDP, cephalic duodenopancreatectomy; CAS, caspofungin; COPD, chronic obstructive pulmonary disease; CVID, common variable immunodeficiency; FLC, fluconazole; NHL, non-Hodgkin lymphoma; NA, not applicable; PPI, proton pump inhibitor; UTI, urinary tract infection. †Degastrogastrectomy and hepatico–jejunal and gastrointestinal anastomosis. ‡Peroral endoscopic myotomy to treat achalasia.
Page created: November 10, 2021
Page updated: December 17, 2021
Page reviewed: December 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.